Hangzhou Tigermed Consulting Co., Ltd. — Proxy Solicitation & Information Statement 2021

Apr 20, 2021

==> picture [51 x 44] intentionally omitted <==

HANGZHOU TIGERMED CONSULTING CO., LTD. 杭州泰格醫藥科技股份有限公司

(A joint stock company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 3347)

Form of Proxy for the 2021 First H Share Class Meeting to be held on

Friday, May 21, 2021

I/We [1]

of

being the registered holder(s) of [2]

H shares of RMB1.00 each in the share capital of Hangzhou Tigermed Consulting Co., Ltd. (the “Company” ) HEREBY APPOINT THE CHAIRMAN OF THE MEETING [3] or

of

as my/our proxy to attend and act for me/us at the 2021 First H Share Class Meeting of the Company to be held on Friday, May 21, 2021 at the Meeting Room, 1/F, Shengda Science Park Tower A, No. 19 Jugong Road, Binjiang District, Hangzhou, the PRC (the “H Share Class Meeting” ) after the conclusion or adjournment of the 2020 annual general meeting ( “AGM” ) and the 2021 first A Share Class Meeting ( “A Share Class Meeting” ), and any adjournment thereof for the purpose of considering and, if thought fit, passing the resolutions as set out in the notice convening the H Share Class Meeting and at the H Share Class Meeting and at any adjournment thereof to vote for me/us and in my/our name(s) in respect of the resolutions as indicated below.

		SPECIAL RESOLUTIONS
	1.	To consider and approve the Partial Repurchase and Cancellation of the 2019 Restricted Shares.
	2.	To consider and approve the Change of the Registered Capital of the Company.
	Date:Notes:1.2.3.4.5.6.7.8.9.

PERSONAL INFORMATION COLLECTION STATEMENT

“Personal Data” in this proxy form has the same meaning as “personal data” in the Personal Data (Privacy) Ordinance, Cap 486 (“ PDPO ”), which includes your name and address.

Your and your proxy’s Personal Data provided in this proxy form will be used in connection with processing your request for the appointment of a proxy to attend, act and vote on your behalf as directed above at the Annual General Meeting. The supply of your and your proxy’s Personal Data is on voluntary basis. However, we may not be able to process your request unless you provide us with your and your proxy’s Personal Data.

Your and your proxy’s Personal Data will be disclosed or transferred to the Company, the Company’s H Share registrar and/or other companies or bodies for the purpose stated above, or when it is required to do so by law, for example, in response to a court order or a law enforcement agency’s request, and will be retained for such period as may be necessary for our verification and record purpose.

By providing your proxy’s Personal Data in this proxy form, you should have obtained the express consent (which has not been withdrawn in writing) from your proxy in using his/her Personal Data provided in this proxy form and that you have informed your proxy of the purpose for and the manner in which his/her Personal Data may be used.

You/your proxy have/has the right to request access to and/or correction of your/your proxy’s Personal Data respectively in accordance with the provisions of the PDPO. Any such request for access to and/or correction of your Personal Data should be in writing to the Privacy Compliance Officer of Tricor Investor Services Limited at the above address.